Cookie Policy

We've put some small files called essential cookies on your device to help our site work on your browser.
We also use analytical cookies to help up improve our website by collecting and reporting information on it's usage.

You can read more above this on our Privacy Policy page.

I'm ok with analytical cookies Do not use analytics cookies

Investors Video and Audio

The content of all investor relations materials contained on this website are deemed to be correct at the time of issue/publication.


Tim Watts updates investors on its track to launch Accrufer, its iron deficiency treatment, in the US by the end of next month

May 2021 - 05:17

Tim Watts, CEO provides an update on US commercialisation progress

May 2021 - 1:00:33

Tim Watts, CEO of Shield Therapeutics #STX explains why they listed the company’s shares on the OTCQX in the United States.

May 2021 - 05:32

Shield Therapeutics says OTCQX Best Market listing ahead of Accrufer US launch has ‘great potential’

May 2021 - 04:13

Shield Therapeutics (LON:STX) Presenting at the Proactive One2One Virtual Forum

Apr 2021 - 38:01

SHIELD THERAPEUTICS PLC – Investor Presentation 9th March 2021

Mar 2021 - 1:02:09

Tim Watts, CEO updates on US commercialisation plans

Mar 2021 - 53:12

Shield Therapeutics raise £25m to launch Accrufer in US

Mar 2021 - 7:04

Tim Watts, CEO of Shield Therapeutics underlines some of the highlights in a business and trading update

Jan 2021 - 12:45

Shield Therapeutics remain optimistic about US commercialisation of Accrufer in the US

Jan 2021 - 14:36

Tim Watts, CEO provides an investor update on recent progress and future plans.

Dec 2020 - 1:23:20

Shield Therapeutics update on U.S. Commercialisation

Dec 2020 - 11:14